Abstract:A closed‐form mathematical model is demonstrated and validated to automatically optimize the imaging parameters for PEGylated ultrasmall iron oxide nanoparticles (PUSIONPs)‐enhanced magnetic resonance angiography (MRA), and the adaptive sequence parameters obtain better signal enhancement than the fixed ones during the prolonged measurement window. The PEGylated ultrasmall iron oxide nanoparticles (PUSIONPs) exhibit longer blood residence time and better biodegradability than conventional gadolinium‐based contrast agents (GBCAs), enabling prolonged acquisitions in contrast‐enhanced magnetic resonance angiography (CE‐MRA) applications. The image quality of CE‐MRA is dependent on the contrast agent concentration and the parameters of the pulse sequences. Here, a closed‐form mathematical model is demonstrated and validated to automatically optimize the concentration, echo time (TE), repetition time (TR) and flip angle (FA). The pharmacokinetic studies are performed to estimate the dynamic intravascular concentrations within 12 h postinjection, and the adaptive concentration‐dependent sequence parameters are determined to achieve optimal signal enhancement during a prolonged measurement window. The presented model is tested on phantom and in vivo rat images acquired from a 3T scanner. Imaging results demonstrate excellent agreement between experimental measurements and theoretical predictions, and the adaptive sequence parameters obtain better signal enhancement than the fixed ones. The low‐dose PUSIONPs (0.03 mmol kg−1 and 0.05 mmol kg−1) give a comparable signal intensity to the high‐dose one (0.10 mmol kg−1) within 2 h postinjection. The presented mathematical model provides guidance for the optimization of the concentration and sequence parameters in PUSIONPs‐enhanced MRA, and has great potential for further clinical translation.

Ultrasmall catechol-PEG-anchored ferrite nanoparticles for high-sensitive magnetic resonance angiography

Progress in ultrasmall ferrite nanoparticles enhanced T1 magnetic resonance angiography

Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography

Ultra-small Manganese Dioxide Nanoparticles with High T1 Relaxivity for Magnetic Resonance Angiography.

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Red Blood Cell Membrane-Coated Ultrasmall NaGdF 4 Nanoprobes for High-Resolution 3D Magnetic Resonance Angiography

Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography.

High-Performance Upconversion Nanoprobes for Multimodal Mr Imaging of Acute Ischemic Stroke

Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging

Magnetic Resonance Angiography with Hour‐Scale Duration after Single Low‐Dose Administration of Biocompatible Gadolinium Oxide Nanoprobe

Using Adaptive Imaging Parameters to Improve PEGylated Ultrasmall Iron Oxide Nanoparticles‐Enhanced Magnetic Resonance Angiography

Boosting Vascular Imaging‐Performance and Systemic Biosafety of Ultra‐Small NaGdF4 Nanoparticles Via Surface Engineering with Rationally Designed Novel Hydrophilic Block Co‐Polymer

Highly Sensitive Early Diagnosis of Kidney Damage Using Renal Clearable Zwitterion‐Coated Ferrite Nanoprobe via Magnetic Resonance Imaging In Vivo

PEGylated amphiphilic polymeric manganese(II) complexes as magnetic resonance angiographic agents

Boosting Vascular Imaging‐Performance and Systemic Biosafety of Ultra‐Small NaGdF 4 Nanoparticles via Surface Engineering with Rationally Designed Novel Hydrophilic Block Co‐Polymer

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Ultrasmall Ferrite Nanoparticles Synthesized Via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent.

Coating Engineering of Mnfe2o4 Nanoparticles with Superhigh T-2 Relaxivity and Efficient Cellular Uptake for Highly Sensitive Magnetic Resonance Imaging

An Ultrahigh-Field-Tailored T1 -T2 Dual-Mode MRI Contrast Agent for High-Performance Vascular Imaging

Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for T1 MR liver imaging

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.